ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Patrick Burnett sold $163K of Arcutis Biotherapeutics, Inc.
Sold$162,515
$10.14Price
16,023Shares
−11%Stake
What ARQT did after the filing
- The stock from Wed, Nov 27 open, $11.60
- +14.5%
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Jan 14 close.
Traded Fri, Nov 22. Filed Tue, Nov 26, 4:21 PM ET, after the close. Returns use the Nov 27 open and the Jan 14 close. Not investment advice.